查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
胜?原料药CDMO服务的全球市场的考察，预测(～2030年)
市场调查报告书
商品编码
1432267

胜?原料药CDMO服务的全球市场的考察，预测(～2030年)

Global Peptide API CDMO Services Market Insights, Forecast to 2030
出版日期: | 出版商: QYResearch | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球胜?原料药CDMO服务市场规模预计将从2024年的23.4221亿美元成长到2030年的54.4797亿美元，预测期内复合年增长率（CAGR）预计为15.11%。

在2024年至2030年的预测期内，美国和加拿大的胜?原料药CDMO服务的市场规模预计将从2024年的12.1966亿美元增长到2030年的27.51亿美元。复合年增长率预计为为14.52%。

中国多?原料药CDMO服务市场规模预计将从2024年的20,566万美元成长至2030年的6,3,865万美元，复合年增长率预计为20.79%。

欧洲胜?原料药 CDMO 服务市场规模预计将从 2024 年的 7.5896 亿美元成长到 2030 年的 16.5534 亿美元，复合年增长率预计为 13.88%。

全球领先的胜?原料药CDMO服务公司包括Bachem、PolyPeptide、CordenPharma、AmbioPharm、USV Peptides、Thermo Fisher、Bio Basic、JPT、金斯瑞、中华?公司等。2023年，全球前5名企业的营收占比约为54.92%。

本报告提供全球胜?原料药CDMO服务市场相关调查，提供市场概要，以及各企业，各类型，各用途，各地区的趋势，及加入此市场的主要企业简介等资讯。

目录

第1章 报告概要

  • 调查范围
  • 各类型市场分析
  • 各用途市场
  • 前提与限制
  • 调查目的
  • 对象年

第2章 全球成长趋势

  • 全球胜?原料药CDMO服务市场预测(2019年～2030年)
  • 世界胜?原料药CDMO服务的成长趋势，各地区
  • 胜?原料药CDMO服务市场动态

第3章 主要加入企业的竞争情形

第4章 胜?原料药CDMO服务的明细资料，各类型

  • 全球胜?原料药CDMO服务市场规模实际成果(2019年～2024年)，各类型
  • 全球胜?原料药CDMO服务市场规模预测(2025年～2030年)，各类型

第5章 胜?原料药CDMO服务的明细资料，各用途

  • 全球胜?原料药CDMO服务市场规模实际成果(2019年～2024年)，各用途
  • 全球胜?原料药CDMO服务市场规模预测(2025年～2030年)，各用途

第6章 北美

第7章 欧洲

第8章 中国

第9章 亚洲(中国以外)

第10章 中东·非洲，南美

第11章 主要加入企业的简介

  • Bachem
  • PolyPeptide
  • CordenPharma
  • AmbioPharm
  • USV Peptides
  • Thermo Fisher
  • Bio Basic
  • JPT
  • Genscript
  • Chinese Peptide Company
  • ScinoPharm
  • ChengDu ShengNuo Biotec
  • CBL
  • Piramal Pharma
  • CPC Scientific

第12章 分析师的观点/结论

第13章 附录

The global Peptide API CDMO Services market is projected to grow from US$ 2342.21 million in 2024 to US$ 5447.97 million by 2030, at a Compound Annual Growth Rate (CAGR) of 15.11% during the forecast period.

The US & Canada market for Peptide API CDMO Services is estimated to increase from $ 1219.66 million in 2024 to reach $ 2751.00 million by 2030, at a CAGR of 14.52% during the forecast period of 2024 through 2030.

The China market for Peptide API CDMO Services is estimated to increase from $ 205.66 million in 2024 to reach $ 638.65 million by 2030, at a CAGR of 20.79% during the forecast period of 2024 through 2030.

The Europe market for Peptide API CDMO Services is estimated to increase from $ 758.96 million in 2024 to reach $ 1655.34 million by 2030, at a CAGR of 13.88% during the forecast period of 2024 through 2030.

The global key companies of Peptide API CDMO Services include Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermo Fisher, Bio Basic, JPT, Genscript, Chinese Peptide Company, etc. In 2023, the global top five players had a share approximately 54.92% in terms of revenue.

Report Includes

This report presents an overview of global market for Peptide API CDMO Services market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Peptide API CDMO Services, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Peptide API CDMO Services, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Peptide API CDMO Services revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Peptide API CDMO Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Peptide API CDMO Services revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermo Fisher, Bio Basic, JPT, Genscript, Chinese Peptide Company, etc.

Market Segmentation

By Company

  • Bachem
  • PolyPeptide
  • CordenPharma
  • AmbioPharm
  • USV Peptides
  • Thermo Fisher
  • Bio Basic
  • JPT
  • Genscript
  • Chinese Peptide Company
  • ScinoPharm
  • ChengDu ShengNuo Biotec
  • CBL
  • Piramal Pharma
  • CPC Scientific

Segment by Type

  • GMP Services
  • Non-GMP Services

Segment by Application

  • Commercial
  • Scientific Research
  • Other

By Region

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Rest of Europe
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Israel
  • GCC Countries
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Peptide API CDMO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Peptide API CDMO Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.

Chapter 7: Europe by Type, by Application and by country, revenue for each segment.

Chapter 8: China by Type, and by Application, revenue for each segment.

Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide API CDMO Services revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Peptide API CDMO Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
    • 1.2.2 GMP Services
    • 1.2.3 Non-GMP Services
  • 1.3 Market by Application
    • 1.3.1 Global Peptide API CDMO Services Market Share by Application: 2019 VS 2023 VS 2030
    • 1.3.2 Commercial
    • 1.3.3 Scientific Research
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Peptide API CDMO Services Market Perspective (2019-2030)
  • 2.2 Global Peptide API CDMO Services Growth Trends by Region
    • 2.2.1 Global Peptide API CDMO Services Market Size by Region: 2019 VS 2023 VS 2030
    • 2.2.2 Peptide API CDMO Services Historic Market Size by Region (2019-2024)
    • 2.2.3 Peptide API CDMO Services Forecasted Market Size by Region (2025-2030)
  • 2.3 Peptide API CDMO Services Market Dynamics
    • 2.3.1 Peptide API CDMO Services Industry Trends
    • 2.3.2 Peptide API CDMO Services Market Drivers
    • 2.3.3 Peptide API CDMO Services Market Challenges
    • 2.3.4 Peptide API CDMO Services Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Peptide API CDMO Services by Players
    • 3.1.1 Global Peptide API CDMO Services Revenue by Players (2019-2024)
    • 3.1.2 Global Peptide API CDMO Services Revenue Market Share by Players (2019-2024)
  • 3.2 Global Peptide API CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Peptide API CDMO Services, Ranking by Revenue, 2022 VS 2023 VS 2024
  • 3.4 Global Peptide API CDMO Services Market Concentration Ratio
    • 3.4.1 Global Peptide API CDMO Services Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 3 and Top 5 Companies by Peptide API CDMO Services Revenue in 2023
  • 3.5 Global Key Players of Peptide API CDMO Services Head office and Area Served
  • 3.6 Global Key Players of Peptide API CDMO Services, Product and Application
  • 3.7 Global Key Players of Peptide API CDMO Services Established Date
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide API CDMO Services Breakdown Data by Type

  • 4.1 Global Peptide API CDMO Services Historic Market Size by Type (2019-2024)
  • 4.2 Global Peptide API CDMO Services Forecasted Market Size by Type (2025-2030)

5 Peptide API CDMO Services Breakdown Data by Application

  • 5.1 Global Peptide API CDMO Services Historic Market Size by Application (2019-2024)
  • 5.2 Global Peptide API CDMO Services Forecasted Market Size by Application (2025-2030)

6 North America

  • 6.1 North America Peptide API CDMO Services Market Size (2019-2030)
  • 6.2 North America Peptide API CDMO Services Market Size by Type
    • 6.2.1 North America Peptide API CDMO Services Market Size by Type (2019-2024)
    • 6.2.2 North America Peptide API CDMO Services Market Size by Type (2025-2030)
    • 6.2.3 North America Peptide API CDMO Services Market Share by Type (2019-2030)
  • 6.3 North America Peptide API CDMO Services Market Size by Application
    • 6.3.1 North America Peptide API CDMO Services Market Size by Application (2019-2024)
    • 6.3.2 North America Peptide API CDMO Services Market Size by Application (2025-2030)
    • 6.3.3 North America Peptide API CDMO Services Market Share by Application (2019-2030)
  • 6.4 North America Peptide API CDMO Services Market Size by Country
    • 6.4.1 North America Peptide API CDMO Services Market Size by Country: 2019 VS 2023 VS 2030
    • 6.4.2 North America Peptide API CDMO Services Market Size by Country (2019-2024)
    • 6.4.3 North America Peptide API CDMO Services Market Share by Country (2025-2030)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Peptide API CDMO Services Market Size (2019-2030)
  • 7.2 Europe Peptide API CDMO Services Market Size by Type
    • 7.2.1 Europe Peptide API CDMO Services Market Size by Type (2019-2024)
    • 7.2.2 Europe Peptide API CDMO Services Market Size by Type (2025-2030)
    • 7.2.3 Europe Peptide API CDMO Services Market Share by Type (2019-2030)
  • 7.3 Europe Peptide API CDMO Services Market Size by Application
    • 7.3.1 Europe Peptide API CDMO Services Market Size by Application (2019-2024)
    • 7.3.2 Europe Peptide API CDMO Services Market Size by Application (2025-2030)
    • 7.3.3 Europe Peptide API CDMO Services Market Share by Application (2019-2030)
  • 7.4 Europe Peptide API CDMO Services Market Size by Country
    • 7.4.1 Europe Peptide API CDMO Services Market Size by Country: 2019 VS 2023 VS 2030
    • 7.4.2 Europe Peptide API CDMO Services Market Size by Country (2019-2024)
    • 7.4.3 Europe Peptide API CDMO Services Market Size by Country (2025-2030)
    • 7.4.4 Germany
    • 7.4.5 France
    • 7.4.6 U.K.
    • 7.4.7 Italy
    • 7.4.8 Russia

8 China

  • 8.1 China Peptide API CDMO Services Market Size (2019-2030)
  • 8.2 China Peptide API CDMO Services Market Size by Type
    • 8.2.1 China Peptide API CDMO Services Market Size by Type (2019-2024)
    • 8.2.2 China Peptide API CDMO Services Market Size by Type (2025-2030)
    • 8.2.3 China Peptide API CDMO Services Market Share by Type (2019-2030)
  • 8.3 China Peptide API CDMO Services Market Size by Application
    • 8.3.1 China Peptide API CDMO Services Market Size by Application (2019-2024)
    • 8.3.2 China Peptide API CDMO Services Market Size by Application (2025-2030)
    • 8.3.3 China Peptide API CDMO Services Market Share by Application (2019-2030)

9 Asia (excluding China)

  • 9.1 Asia Peptide API CDMO Services Market Size (2019-2030)
  • 9.2 Asia Peptide API CDMO Services Market Size by Type
    • 9.2.1 Asia Peptide API CDMO Services Market Size by Type (2019-2024)
    • 9.2.2 Asia Peptide API CDMO Services Market Size by Type (2025-2030)
    • 9.2.3 Asia Peptide API CDMO Services Market Share by Type (2019-2030)
  • 9.3 Asia Peptide API CDMO Services Market Size by Application
    • 9.3.1 Asia Peptide API CDMO Services Market Size by Application (2019-2024)
    • 9.3.2 Asia Peptide API CDMO Services Market Size by Application (2025-2030)
    • 9.3.3 Asia Peptide API CDMO Services Market Share by Application (2019-2030)
  • 9.4 Asia Peptide API CDMO Services Market Size by Region
    • 9.4.1 Asia Peptide API CDMO Services Market Size by Region: 2019 VS 2023 VS 2030
    • 9.4.2 Asia Peptide API CDMO Services Market Size by Region (2019-2024)
    • 9.4.3 Asia Peptide API CDMO Services Market Size by Region (2025-2030)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 Southeast Asia
    • 9.4.7 India
    • 9.4.8 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size (2019-2030)
  • 10.2 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Type (2019-2024)
    • 10.2.2 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Type (2025-2030)
    • 10.2.3 Middle East, Africa, and Latin America Peptide API CDMO Services Market Share by Type (2019-2030)
  • 10.3 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Application (2019-2024)
    • 10.3.2 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Application (2025-2030)
    • 10.3.3 Middle East, Africa, and Latin America Peptide API CDMO Services Market Share by Application (2019-2030)
  • 10.4 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Country: 2019 VS 2023 VS 2030
    • 10.4.2 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Country (2019-2024)
    • 10.4.3 Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Country (2025-2030)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Israel
    • 10.4.8 GCC Countries

11 Key Players Profiles

  • 11.1 Bachem
    • 11.1.1 Bachem Company Details
    • 11.1.2 Bachem Business Overview
    • 11.1.3 Bachem Peptide API CDMO Services Introduction
    • 11.1.4 Bachem Revenue in Peptide API CDMO Services Business (2019-2024)
    • 11.1.5 Bachem Recent Development
  • 11.2 PolyPeptide
    • 11.2.1 PolyPeptide Company Details
    • 11.2.2 PolyPeptide Business Overview
    • 11.2.3 PolyPeptide Peptide API CDMO Services Introduction
    • 11.2.4 PolyPeptide Revenue in Peptide API CDMO Services Business (2019-2024)
    • 11.2.5 PolyPeptide Recent Development
  • 11.3 CordenPharma
    • 11.3.1 CordenPharma Company Details
    • 11.3.2 CordenPharma Business Overview
    • 11.3.3 CordenPharma Peptide API CDMO Services Introduction
    • 11.3.4 CordenPharma Revenue in Peptide API CDMO Services Business (2019-2024)
    • 11.3.5 CordenPharma Recent Development
  • 11.4 AmbioPharm
    • 11.4.1 AmbioPharm Company Details
    • 11.4.2 AmbioPharm Business Overview
    • 11.4.3 AmbioPharm Peptide API CDMO Services Introduction
    • 11.4.4 AmbioPharm Revenue in Peptide API CDMO Services Business (2019-2024)
    • 11.4.5 AmbioPharm Recent Development
  • 11.5 USV Peptides
    • 11.5.1 USV Peptides Company Details
    • 11.5.2 USV Peptides Business Overview
    • 11.5.3 USV Peptides Peptide API CDMO Services Introduction
    • 11.5.4 USV Peptides Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.6 Thermo Fisher
    • 11.6.1 Thermo Fisher Company Details
    • 11.6.2 Thermo Fisher Business Overview
    • 11.6.3 Thermo Fisher Peptide API CDMO Services Introduction
    • 11.6.4 Thermo Fisher Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.7 Bio Basic
    • 11.7.1 Bio Basic Company Details
    • 11.7.2 Bio Basic Business Overview
    • 11.7.3 Bio Basic Peptide API CDMO Services Introduction
    • 11.7.4 Bio Basic Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.8 JPT
    • 11.8.1 JPT Company Details
    • 11.8.2 JPT Business Overview
    • 11.8.3 JPT Peptide API CDMO Services Introduction
    • 11.8.4 JPT Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.9 Genscript
    • 11.9.1 Genscript Company Details
    • 11.9.2 Genscript Business Overview
    • 11.9.3 Genscript Peptide API CDMO Services Introduction
    • 11.9.4 Genscript Revenue in Peptide API CDMO Services Business (2019-2024)
    • 11.9.5 Genscript Recent Development
  • 11.10 Chinese Peptide Company
    • 11.10.1 Chinese Peptide Company Company Details
    • 11.10.2 Chinese Peptide Company Business Overview
    • 11.10.3 Chinese Peptide Company Peptide API CDMO Services Introduction
    • 11.10.4 Chinese Peptide Company Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.11 ScinoPharm
    • 11.11.1 ScinoPharm Company Details
    • 11.11.2 ScinoPharm Business Overview
    • 11.11.3 ScinoPharm Peptide API CDMO Services Introduction
    • 11.11.4 ScinoPharm Revenue in Peptide API CDMO Services Business (2019-2024)
    • 11.11.5 ScinoPharm Recent Development
  • 11.12 ChengDu ShengNuo Biotec
    • 11.12.1 ChengDu ShengNuo Biotec Company Details
    • 11.12.2 ChengDu ShengNuo Biotec Business Overview
    • 11.12.3 ChengDu ShengNuo Biotec Peptide API CDMO Services Introduction
    • 11.12.4 ChengDu ShengNuo Biotec Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.13 CBL
    • 11.13.1 CBL Company Details
    • 11.13.2 CBL Business Overview
    • 11.13.3 CBL Peptide API CDMO Services Introduction
    • 11.13.4 CBL Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.14 Piramal Pharma
    • 11.14.1 Piramal Pharma Company Details
    • 11.14.2 Piramal Pharma Business Overview
    • 11.14.3 Piramal Pharma Peptide API CDMO Services Introduction
    • 11.14.4 Piramal Pharma Revenue in Peptide API CDMO Services Business (2019-2024)
  • 11.15 CPC Scientific
    • 11.15.1 CPC Scientific Company Details
    • 11.15.2 CPC Scientific Business Overview
    • 11.15.3 CPC Scientific Peptide API CDMO Services Introduction
    • 11.15.4 CPC Scientific Revenue in Peptide API CDMO Services Business (2019-2024)
    • 11.15.5 CPC Scientific Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer

List of Tables

  • Table 1. Global Peptide API CDMO Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
  • Table 2. Key Players of GMP Services
  • Table 3. Key Players of Non-GMP Services
  • Table 4. Global Peptide API CDMO Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
  • Table 5. Global Peptide API CDMO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
  • Table 6. Global Peptide API CDMO Services Market Size by Region (2019-2024) & (US$ Million)
  • Table 7. Global Peptide API CDMO Services Market Share by Region (2019-2024)
  • Table 8. Global Peptide API CDMO Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
  • Table 9. Global Peptide API CDMO Services Market Share by Region (2025-2030)
  • Table 10. Peptide API CDMO Services Market Trends
  • Table 11. Peptide API CDMO Services Market Drivers
  • Table 12. Peptide API CDMO Services Market Challenges
  • Table 13. Peptide API CDMO Services Market Restraints
  • Table 14. Global Peptide API CDMO Services Revenue by Players (2019-2024) & (US$ Million)
  • Table 15. Global Peptide API CDMO Services Market Share by Players (2019-2024)
  • Table 16. Global Top Peptide API CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide API CDMO Services as of 2023)
  • Table 17. Global Peptide API CDMO Services Industry Ranking 2022 VS 2023
  • Table 18. Global 5 Largest Players Market Share by Peptide API CDMO Services Revenue (CR5 and HHI) & (2019-2024)
  • Table 19. Global Key Players of Peptide API CDMO Services, Headquarters and Area Served
  • Table 20. Global Key Players of Peptide API CDMO Services, Product and Application
  • Table 21. Global Key Players of Peptide API CDMO Services Established Date
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Peptide API CDMO Services Market Size by Type (2019-2024) & (US$ Million)
  • Table 24. Global Peptide API CDMO Services Revenue Market Share by Type (2019-2024)
  • Table 25. Global Peptide API CDMO Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
  • Table 26. Global Peptide API CDMO Services Revenue Market Share by Type (2025-2030)
  • Table 27. Global Peptide API CDMO Services Market Size by Application (2019-2024) & (US$ Million)
  • Table 28. Global Peptide API CDMO Services Revenue Market Share by Application (2019-2024)
  • Table 29. Global Peptide API CDMO Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
  • Table 30. Global Peptide API CDMO Services Revenue Market Share by Application (2025-2030)
  • Table 31. North America Peptide API CDMO Services Market Size by Type (2019-2024) & (US$ Million)
  • Table 32. North America Peptide API CDMO Services Market Size by Type (2025-2030) & (US$ Million)
  • Table 33. North America Peptide API CDMO Services Market Size by Application (2019-2024) & (US$ Million)
  • Table 34. North America Peptide API CDMO Services Market Size by Application (2025-2030) & (US$ Million)
  • Table 35. North America Peptide API CDMO Services Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 36. North America Peptide API CDMO Services Market Size by Country (2019-2024) & (US$ Million)
  • Table 37. North America Peptide API CDMO Services Market Size by Country (2025-2030) & (US$ Million)
  • Table 38. Europe Peptide API CDMO Services Market Size by Type (2019-2024) & (US$ Million)
  • Table 39. Europe Peptide API CDMO Services Market Size by Type (2025-2030) & (US$ Million)
  • Table 40. Europe Peptide API CDMO Services Market Size by Application (2019-2024) & (US$ Million)
  • Table 41. Europe Peptide API CDMO Services Market Size by Application (2025-2030) & (US$ Million)
  • Table 42. Europe Peptide API CDMO Services Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 43. Europe Peptide API CDMO Services Market Size by Country (2019-2024) & (US$ Million)
  • Table 44. Europe Peptide API CDMO Services Market Size by Country (2025-2030) & (US$ Million)
  • Table 45. China Peptide API CDMO Services Market Size by Type (2019-2024) & (US$ Million)
  • Table 46. China Peptide API CDMO Services Market Size by Type (2025-2030) & (US$ Million)
  • Table 47. China Peptide API CDMO Services Market Size by Application (2019-2024) & (US$ Million)
  • Table 48. China Peptide API CDMO Services Market Size by Application (2025-2030) & (US$ Million)
  • Table 49. Asia Peptide API CDMO Services Market Size by Type (2019-2024) & (US$ Million)
  • Table 50. Asia Peptide API CDMO Services Market Size by Type (2025-2030) & (US$ Million)
  • Table 51. Asia Peptide API CDMO Services Market Size by Application (2019-2024) & (US$ Million)
  • Table 52. Asia Peptide API CDMO Services Market Size by Application (2025-2030) & (US$ Million)
  • Table 53. Asia Peptide API CDMO Services Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
  • Table 54. Asia Peptide API CDMO Services Market Size by Region (2019-2024) & (US$ Million)
  • Table 55. Asia Peptide API CDMO Services Market Size by Region (2025-2030) & (US$ Million)
  • Table 56. Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Type (2019-2024) & (US$ Million)
  • Table 57. Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Type (2025-2030) & (US$ Million)
  • Table 58. Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Application (2019-2024) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Application (2025-2030) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Peptide API CDMO Services Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
  • Table 61. Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Country (2019-2024) & (US$ Million)
  • Table 62. Middle East, Africa, and Latin America Peptide API CDMO Services Market Size by Country (2025-2030) & (US$ Million)
  • Table 63. Bachem Company Details
  • Table 64. Bachem Business Overview
  • Table 65. Bachem Peptide API CDMO Services Product
  • Table 66. Bachem Revenue in Peptide API CDMO Services Business (2019-2024) & (US$ Million)
  • Table 67. Bachem Recent Development
  • Table 68. PolyPeptide Company Details
  • Table 69. PolyPeptide Business Overview
  • Table 70. PolyPeptide Peptide API CDMO Services Product
  • Table 71. PolyPeptide Revenue in Peptide API CDMO Services Business (2019-2024) & (US$ Million)
  • Table 72. PolyPeptide Recent Development
  • Table 73. CordenPharma Company Details
  • Table 74. CordenPharma Business Overview
  • Table 75. CordenPharma Peptide API CDMO Services Product
  • Table 76. CordenPharma Revenue in Peptide API CDMO Services Business (2019-2024) & (US$ Million)
  • Table 77. CordenPharma Recent Development
  • Table 78. AmbioPharm Company Details
  • Table 79. AmbioPharm Business Overview
  • Table 80. AmbioPharm Peptide API CDMO Services Product
  • Table 81. AmbioPharm Revenue in Peptide API CDMO Services Business (2019-2024) & (US$ Million)
  • Table 82. AmbioPharm Recent Development
  • Table 83. USV Peptides Company Details
  • Table 84. USV Peptides Business Overview
  • Table 85. USV Peptides Peptide API CDMO Services Product
  • Table 86. USV Peptides Revenue in Peptide API CDMO Services Business (2019-2024) & (US$ Million)
  • Table 87. Thermo Fisher Company Details
  • Table 88. Thermo Fisher Business Overview
  • Table 89. Thermo Fisher Peptide API CDMO Services Product
  • Table 90. Thermo Fisher Revenue in Peptide API CDMO Services Business (2019-2024) & (US$ Million)
  • Table 91. Bio Basic Company Details
  • Table 92. Bio Basic Business Overview
  • Table 93. Bio Basic Peptide API CDMO Services Product
  • Table 94. Bio Basic Revenue in Peptide API CDMO Services Business (2019-2024) & (US$ Million)
  • Table 95. JPT Company Details
  • Table 96. JPT Business Overview
  • Table 97. JPT Peptide API CDMO Services Product
  • Table 98. JPT Revenue in Peptide API CDMO Services Business (2019-2024) & (US$ Million)
  • Table 99. Genscript Company Details
  • Table 100. Genscript Business Overview
  • Table 101. Genscript Peptide API CDMO Services Product
  • Table 102. Genscript Revenue in Peptide API CDMO Services Business (2019-2024) & (US$ Million)
  • Table 103. Genscript Recent Development
  • Table 104. Chinese Peptide Company Company Details
  • Table 105. Chinese Peptide Company Business Overview
  • Table 106. Chinese Peptide Company Peptide API CDMO Services Product
  • Table 107. Chinese Peptide Company Revenue in Peptide API CDMO Services Business (2019-2024) & (US$ Million)
  • Table 108. ScinoPharm Company Details
  • Table 109. ScinoPharm Business Overview
  • Table 110. ScinoPharm Peptide API CDMO Services Product
  • Table 111. ScinoPharm Revenue in Peptide API CDMO Services Business (2019-2024) & (US$ Million)
  • Table 112. ScinoPharm Recent Development
  • Table 113. ChengDu ShengNuo Biotec Company Details
  • Table 114. ChengDu ShengNuo Biotec Business Overview
  • Table 115. ChengDu ShengNuo Biotec Peptide API CDMO Services Product
  • Table 116. ChengDu ShengNuo Biotec Revenue in Peptide API CDMO Services Business (2019-2024) & (US$ Million)
  • Table 117. CBL Company Details
  • Table 118. CBL Business Overview
  • Table 119. CBL Peptide API CDMO Services Product
  • Table 120. CBL Revenue in Peptide API CDMO Services Business (2019-2024) & (US$ Million)
  • Table 121. Piramal Pharma Company Details
  • Table 122. Piramal Pharma Business Overview
  • Table 123. Piramal Pharma Peptide API CDMO Services Product
  • Table 124. Piramal Pharma Revenue in Peptide API CDMO Services Business (2019-2024) & (US$ Million)
  • Table 125. CPC Scientific Company Details
  • Table 126. CPC Scientific Business Overview
  • Table 127. CPC Scientific Peptide API CDMO Services Product
  • Table 128. CPC Scientific Revenue in Peptide API CDMO Services Business (2019-2024) & (US$ Million)
  • Table 129. CPC Scientific Recent Development
  • Table 130. Research Programs/Design for This Report
  • Table 131. Key Data Information from Secondary Sources
  • Table 132. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Peptide API CDMO Services Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 2. Global Peptide API CDMO Services Market Share by Type: 2023 VS 2030
  • Figure 3. Global Peptide API CDMO Services Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
  • Figure 4. Global Peptide API CDMO Services Market Share by Application: 2023 VS 2030
  • Figure 5. Commercial Case Studies
  • Figure 6. Scientific Research Case Studies
  • Figure 7. Peptide API CDMO Services Report Years Considered
  • Figure 8. Global Peptide API CDMO Services Market Size (US$ Million), Year-over-Year: 2019-2030
  • Figure 9. Global Peptide API CDMO Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
  • Figure 10. Global Peptide API CDMO Services Market Share by Region: 2023 VS 2030
  • Figure 11. Global Peptide API CDMO Services Market Share by Players in 2023
  • Figure 12. Global Top Peptide API CDMO Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide API CDMO Services as of 2023)
  • Figure 13. The Top 3 and 5 Players Market Share by Peptide API CDMO Services Revenue in 2023
  • Figure 14. North America Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 15. North America Peptide API CDMO Services Market Share by Type (2019-2030)
  • Figure 16. North America Peptide API CDMO Services Market Share by Application (2019-2030)
  • Figure 17. North America Peptide API CDMO Services Market Share by Country (2019-2030)
  • Figure 18. United States Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 19. Canada Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 20. Europe Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 21. Europe Peptide API CDMO Services Market Share by Type (2019-2030)
  • Figure 22. Europe Peptide API CDMO Services Market Share by Application (2019-2030)
  • Figure 23. Europe Peptide API CDMO Services Market Share by Country (2019-2030)
  • Figure 24. Germany Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 25. France Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 26. U.K. Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 27. Italy Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 28. Russia Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 29. China Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 30. China Peptide API CDMO Services Market Share by Type (2019-2030)
  • Figure 31. China Peptide API CDMO Services Market Share by Application (2019-2030)
  • Figure 32. Asia Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 33. Asia Peptide API CDMO Services Market Share by Type (2019-2030)
  • Figure 34. Asia Peptide API CDMO Services Market Share by Application (2019-2030)
  • Figure 35. Asia Peptide API CDMO Services Market Share by Region (2019-2030)
  • Figure 36. Japan Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 37. South Korea Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 38. Southeast Asia Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 39. India Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 40. Australia Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 41. Middle East, Africa, and Latin America Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 42. Middle East, Africa, and Latin America Peptide API CDMO Services Market Share by Type (2019-2030)
  • Figure 43. Middle East, Africa, and Latin America Peptide API CDMO Services Market Share by Application (2019-2030)
  • Figure 44. Middle East, Africa, and Latin America Peptide API CDMO Services Market Share by Country (2019-2030)
  • Figure 45. Brazil Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 46. Mexico Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 47. Turkey Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 48. Israel Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 49. GCC Countries Peptide API CDMO Services Market Size YoY Growth (2019-2030) & (US$ Million)
  • Figure 50. Bachem Revenue Growth Rate in Peptide API CDMO Services Business (2019-2024)
  • Figure 51. PolyPeptide Revenue Growth Rate in Peptide API CDMO Services Business (2019-2024)
  • Figure 52. CordenPharma Revenue Growth Rate in Peptide API CDMO Services Business (2019-2024)
  • Figure 53. AmbioPharm Revenue Growth Rate in Peptide API CDMO Services Business (2019-2024)
  • Figure 54. USV Peptides Revenue Growth Rate in Peptide API CDMO Services Business (2019-2024)
  • Figure 55. Thermo Fisher Revenue Growth Rate in Peptide API CDMO Services Business (2019-2024)
  • Figure 56. Bio Basic Revenue Growth Rate in Peptide API CDMO Services Business (2019-2024)
  • Figure 57. JPT Revenue Growth Rate in Peptide API CDMO Services Business (2019-2024)
  • Figure 58. Genscript Revenue Growth Rate in Peptide API CDMO Services Business (2019-2024)
  • Figure 59. Chinese Peptide Company Revenue Growth Rate in Peptide API CDMO Services Business (2019-2024)
  • Figure 60. ScinoPharm Revenue Growth Rate in Peptide API CDMO Services Business (2019-2024)
  • Figure 61. ChengDu ShengNuo Biotec Revenue Growth Rate in Peptide API CDMO Services Business (2019-2024)
  • Figure 62. CBL Revenue Growth Rate in Peptide API CDMO Services Business (2019-2024)
  • Figure 63. Piramal Pharma Revenue Growth Rate in Peptide API CDMO Services Business (2019-2024)
  • Figure 64. CPC Scientific Revenue Growth Rate in Peptide API CDMO Services Business (2019-2024)
  • Figure 65. Bottom-up and Top-down Approaches for This Report
  • Figure 66. Data Triangulation
  • Figure 67. Key Executives Interviewed